Accord Healthcare

Every quarter, Accord people nominate individuals or teams for our 'Make it Better awards' - designed to acknowledge the extra mile our people have gone to embody our ethos and help customers and patients. A huge congratulations to all the winners and thank you for those who took the time to nominate them. Your kudos goes a long way in giving credit where its due and empowering our people to see how much their contributions matter. #WeMakeItBetter #AccordHealthcare (S)

We are excited to announce the launch of our new website for Accord Schimatari, Greece. This state-of-the-art facility demonstrates our commitment to providing patients and customers with access to essential medicines. The website includes detailed information about the site, its capabilities, our team members, and our latest job vacancies.  https://ow.ly/c9Ny50UrGiv (S)

With over 5400 drug related deaths registered in England and Wales in 2023 and opiates being responsible in just under half of the cases reported, it is clear the scourge of addiction is an ever-present and growing problem. In the UK alone around 140,000 people receive treatment for opioid disorders each year, which without expert intervention, threatens to destroy the physical and mental health of sufferers and their loved ones. It is clear it is an area that needs ongoing focus and attention from many players, including industry. That is why Accord Healthcare is committed to tackling addiction through our portfolio of medicines and to help those who need it most to overcome addiction. We highlight this commitment today in an article in The Future of Healthcare supplement published by Media Planet in today’s edition of The Telegraph and discuss how continuously adding value to an established range of medications, combined with innovative and flexible approaches to partnership working with the likes of the NHS, the police, academia and other industry partners to improve training and awareness is yielding results and saving lives. https://lnkd.in/e69jYuj2 #futureofhealthcarecampaign2024 #WeMakeItBetter #AccordHealthcare (S)

Congratulations to the winners of our annual 'tache of the year' competition as part of the global #Movember campaign. Over the month-long campaign, colleagues from across Accord Healthcare's network mo'ed their own way to raise awareness of men's health conditions such as prostate cancer, testicular cancer and mental health. Well done to Konstantinos Tsobolis (Greece) for winning first place, followed by John Dunn (UK) in second and Team Hungary in third place. Thank you for showing your support to #MakeItBetter for the men in our lives and community. (S)

Our UK Country Manager, Generics, Clara Carter, recently spoke at the Life Science Access Academy "Generics, Branded Generics, and Biosimilars: NHS Update" panel. Within this, the panel discussed the crucial role of government policy in securing £18 billion in potential NHS savings over the next five years. Clara’s article outlines how better support for biosimilars and generics can unlock these savings and improve patient care. Read the full article to learn more. (s)

This Christmas, our chosen corporate charity International Health Partners (IHP) is giving children a brighter future by ensuring access to the lifesaving medicine they need.   Over half of all child deaths are due to conditions that could be prevented with improved access to healthcare (WHO).   Together with IHP, we believe that no child should suffer due to the lack of healthcare, and are doing what we can to ensure all children have access to medicines and medical supplies to treat everything from infections to childhood cancers.   Donations made by 25th December will be matched, doubling your impact!   Donating is simple - click here for more information www.ihpuk.org. Thank you! (S)

Accord Healthcare is proud to be a finalist in two categories at the #ScripAwards2024 taking place tomorrow in London. Best of luck to all our teams representing and the rest of the nominees! #WeMakeItBetter #AccordHealthcare (S)

It was wonderful to be in Vienna last weekend for this year’s #PROSCA meeting with so many colleagues and partners. As principal sponsors it was a privilege to host the 'Prostate Cancer Playback – highlights of 2024' symposium to kick off the meeting. The speakers took delegates through the latest thinking and research to emerge over the course of 2024 from a urologist’s and medical oncologist’s perspectives and there was a huge amount of debate and conversation with many questions from the floor. As a company dedicated to supporting healthcare professionals to deepen their knowledge and learning, it was an honour to be able to bring together such a strong group or speakers and delegates. We engaged in many insightful and fruitful discussions over the course of the two day meeting on topics ranging from patient support, to improving early diagnosis and how best to support delivery of treatments. It really was a strong multidisciplinary meeting focusing on the implications of new clinical findings in prostate cancer and how they can be applied to the daily practices or Urologists and Oncologists. Thanks to all those who attended the meeting, came to our symposium or visited us on our stand. We look forward to seeing you next year! #PROSCA #WeMakeItBetter #AccordHealthcare (S)

Accord is proud to support International Health Partners with their outstanding relief work through Tearfund UK for the Disasters Emergency Committee Middle East Humanitarian Appeal. With a harrowing number of conflicts and humanitarian disasters currently happening across then world, we remain as committed as ever to working with our corporate charity partners to provide greater access to critical medicines in these areas of suffering. (S)

At Accord Healthcare we recognise that a cancer diagnosis can have a life-changing impact on a person and their loved ones. That is why we are committed to supporting cancer patients at every step of their journey from prevention and early diagnosis to advancing treatments, care and support. We are also dedicated to supporting healthcare professionals at the forefront of treatment and research and so we are honoured to be principal sponsor of #PROSCA 2024. This multidisciplinary meeting focuses on the implications of new clinical findings in prostate cancer and how they can be applied to the daily practices or Urologists and Oncologists. If you are attending please come and visit us at our booth in the exhibition hall! #PROSCA2024 #WeMakeItBetter #AccordHealthcare (S)